pp 86 KRN7000 as a new type of antitumor and immunostimulatory drug Discovery of Agelasphins as new type of antitumor and immunostimulatory compounds. KRN7000, an analog of agelasphins, is developed as a candidate of drug, that stimulate NKT cells through CD1d binding.
